Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Confluent (CFLT) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Confluent (CFLT) over the last 6 years, with Q4 2025 value amounting to $347.2 million.

  • Confluent's Cash & Equivalents fell 1004.46% to $347.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $347.2 million, marking a year-over-year decrease of 1004.46%. This contributed to the annual value of $347.2 million for FY2025, which is 1004.46% down from last year.
  • Latest data reveals that Confluent reported Cash & Equivalents of $347.2 million as of Q4 2025, which was down 1004.46% from $298.5 million recorded in Q3 2025.
  • Over the past 5 years, Confluent's Cash & Equivalents peaked at $1.4 billion during Q4 2021, and registered a low of $44.1 million during Q1 2021.
  • Over the past 5 years, Confluent's median Cash & Equivalents value was $345.3 million (recorded in 2023), while the average stood at $463.9 million.
  • As far as peak fluctuations go, Confluent's Cash & Equivalents skyrocketed by 364006.36% in 2021, and later plummeted by 6832.83% in 2022.
  • Over the past 5 years, Confluent's Cash & Equivalents (Quarter) stood at $1.4 billion in 2021, then tumbled by 68.33% to $435.8 million in 2022, then fell by 19.74% to $349.8 million in 2023, then increased by 10.36% to $386.0 million in 2024, then decreased by 10.04% to $347.2 million in 2025.
  • Its Cash & Equivalents stands at $347.2 million for Q4 2025, versus $298.5 million for Q3 2025 and $295.6 million for Q2 2025.